Company Filing History:
Years Active: 2008
Title: Innovations of Andreas Klaes in Modular Transfection Systems
Introduction
Andreas Klaes is a notable inventor based in Kö'ln, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of modular transfection systems. His innovative approach has the potential to enhance gene therapy techniques for both humans and animals.
Latest Patents
Andreas Klaes holds a patent for a method of transfection of cells using at least one protein capable of forming nucleoprotein filaments. This method involves modifying the protein with functional components that influence the transfection process. The nucleic acid to be transfected is loaded with the modified protein, forming a filament-like complex that is then introduced to the target cells. His invention also includes a transfection agent consisting of nucleoprotein filaments, which can be utilized in pharmaceutical preparations for gene therapy.
Career Highlights
Andreas Klaes is associated with Amaxa AG, a company known for its advancements in transfection technologies. His work has been pivotal in developing methods that improve the efficiency of gene delivery systems. With a focus on innovative solutions, he continues to contribute to the field of biotechnology.
Collaborations
Andreas has collaborated with notable colleagues such as Hanns-Martin Schmidt and Ludger Altrogge. These partnerships have fostered a collaborative environment that enhances the development of cutting-edge technologies in gene therapy.
Conclusion
Andreas Klaes is a prominent figure in the field of biotechnology, with a focus on modular transfection systems. His innovative patent and collaborations highlight his commitment to advancing gene therapy techniques. His work continues to pave the way for future developments in this critical area of research.